ERBB2 and breast cancer: The first immunohistochemical biomarkers which have laid the foundation for the classification of the BC subtypes mainly include the expression of the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).